Endovascular Treatment of Tentorial Dural Arteriovenous Fistulas Using the Transarterial Approach as a First-Line Strategy. Issue 5 (13th February 2021)

• Record Type: Journal Article
• Authors: Rezende, Marco Túlio Salles; Trivelato, Felipe Padovani; de Castro-Afonso, Luis Henrique; Nakiri, Guilherme Seizem; Silva, Caio César Molina; Abud, Thiago Giansante; Colli, Benedicto Oscar; Ulhôa, Alexandre Cordeiro; Abud, Daniel Giansante
• Is Part Of: Operative neurosurgery. Volume 20:Issue 5(2021)
• Page Start: 484
• Page End: 492
• Publication Date: 2021-02-13
• Subjects: Dural arteriovenous fistula -- Embolization -- Tentorium cerebelli; Nervous system -- Surgery -- Periodicals; 617.480590
• DOI: 10.1093/ons/opaa477
• Languages: English
• ISSNs: 2332-4252

Abstract

Abstract: BACKGROUND: In recent decades, endovascular approaches have become the standard treatment for most tentorial dural arteriovenous fistulas (TDAVFs). Although endovascular treatment (EVT) is associated with better clinical outcomes, the angiographic occlusion rates are lower than those of surgical or combined approaches. OBJECTIVE: To evaluate the efficacy and safety of EVT for TDAVFs using the transarterial approach (TAA) as a first-line strategy. METHODS: Clinical and radiological data from 45 consecutive patients with TDAVFs who underwent EVT at 2 centers were retrospectively reviewed. Patient demographics and clinical and angiographic data were registered. Postprocedural and 6-mo follow-up angiographic and clinical results were evaluated. Univariable and multivariable logistic regression were performed to identify angiographic occlusion predictors after the first session and predictors of clinical complications. RESULTS: An isolated TAA was used for 40 TDAVFs (88.9%). A total of 37 (82.2%) TDAVFs were completely occluded after a single EVT session, and 44 TDAVFs (97.8%) were completely occluded after the last procedure. The presence of fewer than 5 arterial feeders was a predictor for total occlusion after the first treatment session (odds ratio [OR], 18.9; 95% CI 2.06-173.57; P = .01). Six-month angiographic control was performed in 42 patients, and all TDAVFs were occluded. Good long-term neurological outcomes were observed in 41 patients (91.1%). Clinical complications occurred in 7 (15.6%) patients. They were related to the number of accessed arteries to perform TAA (odds ratio, 2.53; 95% CI 1.10-5.86; P = .03). The procedure-related mortality rate was 2.2%. CONCLUSION: TAA is a safe and effective treatment for TDAVFs. Graphical Abstract: